USPTO serial 90115249
NAVICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2022
- Examiner
- SCHMIDT, JOHN JOSEPH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NAVICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
Michele H. Bowman ABBOTT LABORATORIES100 ABBOTT PARK ROADABBOTT PARK, IL 60064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software and mobile applications for use in connection with infectious disease testing; downloadable software and mobile applications for infectious disease data and information management; downloadable software and mobile applications for use in the field of infectious disease testing; downloadable software and mobile applications for receiving, storing, displaying, tracking, sharing, reporting, maintaining, and managing infectious disease data and information | ACTIVE | Aug 26, 2020 |
| 042 | Online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for use in connection with infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for infectious disease data and information management; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for use in the field of infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing infectious disease data and information; educational online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, in the field of infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for training in the field of infectious disease testing; providing Internet website portals and web-based software platforms for use in connection with infectious disease testing; providing Internet website portals and web-based software platforms for infectious disease data and information management; providing Internet website portals and web-based software platforms for use in the field of infectious disease testing; providing Internet website portals and web-based software platforms for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing infectious disease data and information; providing educational Internet website portals and web-based software platforms in the field of infectious disease testing; providing Internet website training portals and web-based training platforms in the field of infectious disease testing | ACTIVE | Dec 30, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abbott Laboratories
- Other trademarks owned by Abbott Laboratories
- Other trademarks owned by Abbott Laboratories
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named NAVICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 22, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 21, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 24, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 23, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 25, 2022 | IUAF | USE AMENDMENT FILED | — |
| Feb 25, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 31, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 19, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 2, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 29, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 9, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 15, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 3, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2020 | NWAP | NEW APPLICATION ENTERED | — |